(Q45300992)

English

Identification of oral antidiabetics and their metabolites in human urine by liquid chromatography/tandem mass spectrometry--a matter for doping control analysis

scientific article published in January 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Identification of oral antidiabetics and their metabolites in human urine by liquid chromatography/tandem mass spectrometry--a matter for doping control analysis (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

liquid chromatography-tandem mass spectrometry

1 reference

based on heuristic

inferred from title

1

object named as

Mario Thevis

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Wilhelm Schänzer

3

object named as

Wilhelm Schänzer

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

author name string

Hans Geyer

2

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

publication date

1 January 2005

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Rapid Communications in Mass Spectrometry

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

19

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

928-936

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

describes a project that uses

liquid chromatography-tandem mass spectrometry

1 reference

based on heuristic

inferred from title

The pharmacology of sulfonylureas

1 reference

https://api.crossref.org/works/10.1002%2FRCM.1875

21 January 2018

Insulinotropic meglitinide analogues

1 reference

https://api.crossref.org/works/10.1002%2FRCM.1875

21 January 2018

The mechanisms underlying the unique pharmacodynamics of nateglinide

1 reference

https://api.crossref.org/works/10.1002%2FRCM.1875

21 January 2018

Novel insulin sensitizers: pharmacogenomic aspects

1 reference

https://api.crossref.org/works/10.1002%2FRCM.1875

21 January 2018

Glitazones. Profile of a new class of substances

1 reference

https://api.crossref.org/works/10.1002%2FRCM.1875

21 January 2018

Insulin as a drug of abuse in body building

1 reference

https://api.crossref.org/works/10.1002%2FRCM.1875

21 January 2018

Insulin, growth hormone and sport

1 reference

https://api.crossref.org/works/10.1002%2FRCM.1875

21 January 2018

A simple and sensitive HPLC method for determination of gliclazide in human serum

1 reference

https://api.crossref.org/works/10.1002%2FRCM.1875

21 January 2018

Rapid determination of metformin in human plasma by liquid chromatography-tandem mass spectrometry method

1 reference

https://api.crossref.org/works/10.1002%2FRCM.1875

21 January 2018

Simultaneous determination of pioglitazone and its two active metabolites in human plasma by LC-MS/MS.

1 reference

https://api.crossref.org/works/10.1002%2FRCM.1875

21 January 2018

Application of liquid chromatography-mass spectrometry(n) analyses to the characterization of novel glyburide metabolites formed in vitro

1 reference

https://api.crossref.org/works/10.1002%2FRCM.1875

21 January 2018

Therapeutic renaissance. Biguanides in type-2 diabetes: metformin

1 reference

https://api.crossref.org/works/10.1002%2FRCM.1875

21 January 2018

Identifiers

10.1002/RCM.1875

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45300992&oldid=2144921764"